New strategies for the management of malignant ascites
Identifieur interne : 002B43 ( Istex/Curation ); précédent : 002B42; suivant : 002B44New strategies for the management of malignant ascites
Auteurs : Nancy Preston [Royaume-Uni]Source :
- European Journal of Cancer Care [ 0961-5423 ] ; 1995-12.
Abstract
Intractable malignant ascites accounts for 6% of all hospice admissions. The onset of malignant ascites indicates a poor prognosis, hence minimal supportive therapy is indicated. This paper examines the method of control for malignant ascites presently available to patients, examines their limitations and proposes new strategies for managing intractable malignant ascites. Ascites is discussed in terms of its pathology—that is, as a form of lymphoedema. With this in mind treatment is proposed based upon principles incorporated into lymphoedema management. Nurses have taken a dominant role in the care of patients with lymphoedema and there appears no reason why ascites management cannot become the remit of nurses offering appropriate, but predominantly palliative therapy.
Url:
DOI: 10.1111/j.1365-2354.1995.tb00090.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B43
Links to Exploration step
ISTEX:5D000E3EE9C8D74D6E42CF3F5A24A456B38A3C8DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">New strategies for the management of malignant ascites</title><author><name sortKey="Preston, Nancy" sort="Preston, Nancy" uniqKey="Preston N" first="Nancy" last="Preston">Nancy Preston</name><affiliation wicri:level="1"><mods:affiliation>Centre for Cancer and Palliative Care Studies, ICR/Royal Marsden NHS Trust, Education and Conference Centre, Fulham Rd, London SW3 6JJ, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Cancer and Palliative Care Studies, ICR/Royal Marsden NHS Trust, Education and Conference Centre, Fulham Rd, London SW3 6JJ</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5D000E3EE9C8D74D6E42CF3F5A24A456B38A3C8D</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1111/j.1365-2354.1995.tb00090.x</idno><idno type="url">https://api.istex.fr/document/5D000E3EE9C8D74D6E42CF3F5A24A456B38A3C8D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002B43</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002B43</idno><idno type="wicri:Area/Istex/Curation">002B43</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">New strategies for the management of malignant ascites</title><author><name sortKey="Preston, Nancy" sort="Preston, Nancy" uniqKey="Preston N" first="Nancy" last="Preston">Nancy Preston</name><affiliation wicri:level="1"><mods:affiliation>Centre for Cancer and Palliative Care Studies, ICR/Royal Marsden NHS Trust, Education and Conference Centre, Fulham Rd, London SW3 6JJ, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Cancer and Palliative Care Studies, ICR/Royal Marsden NHS Trust, Education and Conference Centre, Fulham Rd, London SW3 6JJ</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">European Journal of Cancer Care</title><title level="j" type="alt">EUROPEAN JOURNAL OF CANCER CARE</title><idno type="ISSN">0961-5423</idno><idno type="eISSN">1365-2354</idno><imprint><biblScope unit="vol">4</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="178">178</biblScope><biblScope unit="page" to="183">183</biblScope><biblScope unit="page-count">6</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1995-12">1995-12</date></imprint><idno type="ISSN">0961-5423</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0961-5423</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Intractable malignant ascites accounts for 6% of all hospice admissions. The onset of malignant ascites indicates a poor prognosis, hence minimal supportive therapy is indicated. This paper examines the method of control for malignant ascites presently available to patients, examines their limitations and proposes new strategies for managing intractable malignant ascites. Ascites is discussed in terms of its pathology—that is, as a form of lymphoedema. With this in mind treatment is proposed based upon principles incorporated into lymphoedema management. Nurses have taken a dominant role in the care of patients with lymphoedema and there appears no reason why ascites management cannot become the remit of nurses offering appropriate, but predominantly palliative therapy.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B43 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 002B43 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:5D000E3EE9C8D74D6E42CF3F5A24A456B38A3C8D
|texte= New strategies for the management of malignant ascites
}}
| This area was generated with Dilib version V0.6.31. |  |